NEW YORK (360Dx) – Australian molecular diagnostics firm Genetic Technologies today reported A$147,000 (US$117,000) in cash receipts from customers for its fiscal fourth quarter, down 25 percent from A$195,000 in fiscal Q3.

During the quarter, the firm also received A$260,000 for ongoing R&D expenditure as part of the Australian government's R&D tax incentive program, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.